Galactosylated polymeric carriers for liver targeting of sorafenib

International Journal of Pharmaceutics

Volumn 466, Issue 1-2, 2014, Pages 172-180

  Craparo, Emanuela F ^a   Sardo, Carla ^a   Serio, Rosa ^a   Zizzo, Maria G ^a   Bondì, Maria L ^b   Giammona, Gaetano ^a,c   Cavallaro, Gennara ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

^c CNR   (Italy)

Author keywords

Active targeting; Galactosylation; Hepatic cell targeted carriers; Polymeric micelles

Indexed keywords

ALPHA,BETA POLY(N 2 HYDROXYETHYL) (2 AMINOETHYLCARBAMATE)ASPARTAMIDE; CARBOHYDRATE RECEPTOR ASGPR; COPOLYMER; LACTOSE; POLYAMINOACID; POLYLACTIC ACID; POLYLACTIDE; POLYMER; RECEPTOR; SORAFENIB; UNCLASSIFIED DRUG; ALPHA,BETA-POLY((2-HYDROXYETHYL)-ASPARTAMIDE); ANTINEOPLASTIC AGENT; CARBANILAMIDE DERIVATIVE; DRUG CARRIER; ETHYLENEDIAMINE; ETHYLENEDIAMINE DERIVATIVE; GALACTOSE; MICELLE; NICOTINAMIDE; PEPTIDE; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; LIVER; LIVER CELL; LIVER CELL CARCINOMA; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; BLOOD; C57BL MOUSE; CHEMISTRY; FEMALE; KIDNEY; LUNG; METABOLISM; SPLEEN;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; ETHYLENEDIAMINES; FEMALE; GALACTOSE; KIDNEY; LIVER; LUNG; MICE, INBRED C57BL; MICELLES; NIACINAMIDE; PEPTIDES; PHENYLUREA COMPOUNDS; POLYESTERS; SPLEEN;

EID: 84896478542     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.02.047     Document Type: Article

References (43)

1. O. Benny, O. Fainaru, A. Adini, F. Cassiola, L. Bazinet, I. Adini, E. Pravda, Y. Nahmias, S. Koirala, G. Corfas, R.J. D'Amato, and J. Folkman An orally delivered small-molecule formulation with antiangiogenic and anticancer activity Nature Biotechnology 26 2008 799 807 (Pubitemid 351961454)
2. M. Chaparro, L. Gonzàlez Moreno, M. Trapero-Marugàn, J. Medina, and R. Moreno-Otero Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents Alimentary Pharmacology and Therapeutics 28 2008 1269 1277
3. E.F. Craparo, M.C. Ognibene, M.P. Casaletto, G. Pitarresi, G. Teresi, and G. Giammona Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting Nanotechnology 19 2008 485603
4. E.F. Craparo, G. Cavallaro, M.C. Ognibene, G. Teresi, M.L. Bondì, and G. Giammona Amphiphilic poly(hydroxyethylaspartamide) derivative-based micelles as drug delivery systems for ferulic acid Journal of Drug Targeting 17 2009 78 88
5. E.F. Craparo, G. Teresi, M.C. Ognibene, M.P. Casaletto, M.L. Bondì, and G. Cavallaro Nanoparticles based on novel amphiphilic polyaspartamide copolymers Journal of Nanoparticle Research 12 2010 2629 2644
6. E.F. Craparo, G. Teresi, M.L. Bondì, M. Licciardi, and G. Cavallaro Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids International Journal of Pharmaceutics 406 2011 135 144
7. E.F. Craparo, D. Triolo, G. Pitarresi, G. Giammona, and G. Cavallaro Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes Biomacromolecules 14 2013 1838 1849
8. E.F. Craparo, G. Teresi, M. Licciardi, M.L. Bondì, and G. Cavallaro Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment Journal of Biomedical Nanotechnology 9 2013 1107 1122
9. G. Di Stefano, F.P. Colonna, A. Bongini, C. Busi, A. Mattioli, and L. Fiume Ribavirin conjugated with lactosaminated poly-l-lysine. Selective delivery to the liver and increased antiviral activity in mice with viral hepatitis Biochemical Pharmacology 54 1997 357 363 (Pubitemid 27373450)
10. G. Di Stefano, L. Fiume, M. Baglioni, L. Bolondi, C. Busi, P. Chieco, F. Kratz, F. Manaresi, and M. Pariali A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade Liver International 26 2006 726 733 (Pubitemid 43983890)
11. EEC Council Directive 86/609, OJ L 358,1,1 December 12, 1987.
12. L. Fiume, L. Bolondi, C. Busi, P. Chieco, F. Kratz, M. Lanza, A. Mattioli, and G. Di Stefano Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine Journal of Hepatology 43 2005 645 652 (Pubitemid 41253232)
13. L. Fiume, and G. Di Stefano Lactosaminated human albumin, a hepatotropic carrier of drugs European Journal of Pharmaceutical Sciences 40 2010 253 262
14. M.F. Francis, M. Cristea, Y. Yang, and F.M. Winnik Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across caco-2 cells Pharmaceutical Research 22 2005 209 219 (Pubitemid 40487204)
15. E. Galia, E. Nicolaides, D. Horter, R. Lobenberg, C. Reppas, and J.B. Dressman Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharmaceutical Research 15 1998 698 705 (Pubitemid 28275645)
16. G. Gaucher, P. Satturwar, M.-C. Jones, A. Furtos, and J.-C. Leroux Polymeric micelles for oral drug delivery European Journal of Pharmaceutics and Biopharmaceutics 76 2010 147 158
17. G. Giammona, B. Carlisi, and S. Palazzo Reaction of α,β- poly(N-2-hydroxyethyl)-d,l-aspartamide with derivatives of carboxylic acids Journal of Polymer Science Part A: Polymer Chemistry 25 1987 2813 2818
18. A.R. Giles Guidelines for the use of animals in biomedical research Thrombosis and Haemostasis 58 1987 1078 1084
19. I. Hyodo, M. Mizuno, G. Yamada, and T. Tsuji Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma Liver 13 1993 80 85 (Pubitemid 23284306)
20. K. Jain, P. Kesharwani, U. Gupta, and N.K. Jain A review of glycosylated carriers for drug delivery Biomaterials 33 2012 4166 4186
21. P.J. Julyan, L.W. Seymour, D.R. Ferry, S. Daryani, C.M. Boivin, J. Doran, M. David, D. Anderson, C. Christodoulou, A.M. Young, S. Hesslewood, and D.J. Kerr Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine Journal of Controlled Release 57 1999 281 290 (Pubitemid 29073443)
22. R.C. Kane, A.T. Farrell, R. Madabushi, B. Booth, S. Chattopadhyay, R. Sridhara, R. Justice, and R. Pazdur Sorafenib for the treatment of unresectable hepatocellular carcinoma The Oncologist 14 2009 95 100
23. G.M. Keating, and A. Santoro Sorafenib - a review of its use in advanced hepatocellular carcinoma Drugs 69 2009 223 240
24. L. Li, H. Wang, Z.Y. Ong, K. Xu, P.L.R. Ee, S. Zheng, J.L. Hedrick, and Y.Y. Yang Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases Nano Today 5 2010 296 312
25. M. Licciardi, M. Campisi, G. Cavallaro, M. Cervello, A. Azzolina, and G. Giammona Synthesis and characterization of polyaminoacidic polycations for gene delivery Biomaterials 27 2006 2066 2075 (Pubitemid 41759501)
26. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, A.C. de Oliveira, A. Santoro, J.L. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. Bolondi, T.F. Greten, P.R. Galle, J.F. Seitz, I. Borbath, D. Häussinger, T. Giannaris, M. Shan, M. Moscovici, D. Voliotis, and J. Bruix SHARP investigators study group: sorafenib in advanced hepatocellular carcinoma New England Journal of Medicine 359 2008 378 390
27. F. Mathot, A. des Rieux, A. Ariën, Y.-J. Schneider, M. Brewster, and V. Préat Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier Journal of Controlled Release 124 2007 134 143 (Pubitemid 350110487)
28. S.H. Medina, V. Tekumalla, M.V. Chevliakov, D.S. Shewach, W.D. Ensminger, and M.E.H. El-Sayed N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers Biomaterials 32 2011 4118 4129
29. T. Ngawhirunpat, N. Wonglertnirant, P. Opanasopit, U. Ruktanonchai, R. Yoksan, K. Wasanasuk, and S. Chirachanchai Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin Colloids and Surfaces B: Biointerfaces 74 2009 253 259
30. NIH Guide for the Care and Use of Laboratory Animals, NIH Publication no. 80-23 (1985).
31. K. Poelstra, J. Prakash, and L. Beljaars Drug targeting to the diseased liver Journal of Controlled Release 161 2012 188 197
32. P.C.N. Rensen, L.A.J.M. Sliedregt, M. Ferns, E. Kieviet, S.M.W. van Rossenberg, S.H. van Leeuwen, T.J.C. van Berkel, and E.A.L. Biessen Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo Journal of Biological Chemistry 276 2001 37577 37584
33. E. Roger, F. Lagarce, E. Garcion, and J.P. Benoit Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery Nanomedicine 5 2010 287 306
34. B. Song, W. Zhang, R. Peng, J. Huang, T. Nie, Y. Li, Q. Jiang, and R. Gao Synthesis and cell activity of novel galactosylated chitosan as a gene carrier Colloids and Surfaces B: Biointerfaces 70 2009 181 186
35. A. Suo, J. Qian, Y. Yao, and W. Zhang Galactosylated poly(ethylene glycol)-b-poly (l-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterization International Journal of Nanomedicine 5 2010 1029 1038
36. F. Suriano, R. Pratt, J.P.K. Tan, N. Wiradharma, A. Nelson, Y.-Y. Yang, P. Dubois, and J.L. Hedrick Synthesis of a family of amphiphilic glycopolymers via controlled ring-opening polymerization of functionalized cyclic carbonates and their application in drug delivery Biomaterials 31 2010 2637 2645
37. US Food and Drug Administration. FDA approval for sorafenib tosylate. 2010-10-01. Available from: URL: http://www.cancer.gov/cancertopics/druginfo/ fda-sorafenib-tosylate.
38. M. Vertzoni, J. Dressman, J. Butler, J. Hempenstall, and C. Reppas Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds European Journal of Pharmaceutics and Biopharmaceutics 60 2005 413 417 (Pubitemid 40922839)
39. D.-Q. Wu, Z.-Y. Li, C. Li, J.-J. Fan, B. Lu, C. Chang, S.-X. Cheng, X.-Z. Zhang, and R.-X. Zhuo Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy Pharmaceutical Research 27 2010 187 199
40. Y.-T. Wu, K.-G. Lin, C.-M. Huang, C.-H. Chang, Y.-L. Sun, K.-H. Fan, W.-C. Hsu, H.-E. Wang, and S.-B. Lin A new N-acetylgalactosamine containing peptide as a targeting vehicle for mammalian hepatocytes via asialoglycoprotein receptor endocytosis Current Drug Delivery 1 2004 119 127
41. R. Yang, F. Meng, S. Ma, F. Huang, H. Liu, and Z. Zhong Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel Biomacromolecules 12 2011 3047 3055
42. J.-Y. Zhang, B. He, W. Qu, Z. Cui, Y.-B. Wang, H. Zhang, J.-C. Wang, and Q. Zhang Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo Journal of Microencapsulation 28 2011 528 536
43. H. Zheng, X. Zhang, F. Xiong, Z. Zhu, B. Lu, Y. Yin, P. Xu, and Y. Du Preparation, characterization, and tissue distribution in mice of lactosaminated carboxymethyl chitosan nanoparticles Carbohydrate Polymers 83 2011 1139 1145